In some countries, NRT products are widely available through pharmacies and other retail outlets, while in others access is more limited or subject to specific regulatory requirements.

NRT products include nicotine patches, gum, lozenges, inhalators, nasal sprays and oral sprays. These medicinal products are intended to help people stop smoking by providing nicotine without the harmful products produced by tobacco combustion.

Currently, 122 countries market nicotine replacement therapy (NRT) products.

They are:

Afghanistan, Algeria, Andorra, Antigua and Barbuda, Argentina, Armenia, Australia, Austria, Bahamas, Bahrain, Barbados, Belarus, Belgium, Bosnia and Herzegovina, Botswana, Brazil, Brunei, Bulgaria, Canada, Chile, Colombia, Congo, Cook Islands, Costa Rica, Croatia, Cyprus, Czech Republic, Democratic Republic of Congo, Denmark, Dominican Republic, El Salvador, Estonia, Fiji, Finland, France, Gabon, Georgia, Germany, Greece, Guatemala, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Ivory Coast, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Kuwait, Latvia, Lithuania, Luxembourg, Macedonia, Madagascar, Malaysia, Maldives, Malta, Marshall Islands, Mauritius, Mexico, Monaco, Mongolia, Morocco, Namibia, Netherlands, New Zealand, Nicaragua, Niger, Nigeria, Niue, Norway, Oman, Palau, Palestine / West Bank & Gaza strip, Panama, Papua New Guinea, Peru, Philippines, Poland, Qatar, Romania, Saint Kitts and Nevis, Samoa, Saudi Arabia, Senegal, Serbia, Seychelles, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Suriname, Swaziland, Sweden, Switzerland, Thailand, Tonga, Trinidad and Tobago, Tunisia, Turkey, Turkmenistan, Uganda, Ukraine, United Arab Emirates, United Kingdom, United States, Uruguay, Uzbekistan, Vanuatu, Venezuela, Vietnam, Zambia, Zimbabwe,

Nicotine replacement therapy (NRT) is a well-established global market comprising a range of licensed medicinal products used to support smoking cessation. Market size estimates vary depending on product scope, geographic coverage and methodology.

Nicotine replacement therapy (NRT) is regulated as a medicinal product in most countries. Regulatory requirements vary between jurisdictions and may affect product approval, distribution, prescription status and retail availability.